Five Reasons to Join Sight Sciences at AGS 2025 in Washington DC
- Events
Join Sight Sciences at AGS 2025 in Washington, DC, from February 27 to March 1 for an exciting lineup of interactive experiences, expert-led discussions, hands-on technology demonstrations, and collaborative learning opportunities. Whether you are looking for clinical insights, reimbursement discussions, or peer-to-peer case exchanges, AGS is the place to connect.
Here are five key reasons to join us! We look forward to seeing you there.
Hands-On Demos and Insights
Experience live demonstrations of our OMNI® Surgical System and SION® Surgical Instrument during exhibit hours and engage with our team to explore the latest studies and clinical insights.
- The OMNI Surgical System enables an implant-free, ab interno minimally invasive glaucoma surgery (“MIGS”) procedure intended to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The procedure targets three key areas of outflow resistance (Schlemm’s canal, collector channels, and trabecular meshwork) and can be performed in combination with or independent of cataract surgery.
- SION represents a new chapter in goniotomy innovation, designed to enable a smooth and gentle procedure. Its bladeless design of the tip and the tissue collection window facilitate smooth navigation and clear visibility.
Don’t Miss Our Lunch Symposium: A Crucial Choice in Glaucoma Treatment
Join us for a thought-provoking lunch symposium on Saturday, March 1, on the AGS Main Stage as leading experts explore a pivotal question: Will You Wait or Act? The Crucial Choice in Combating Glaucoma with Interventional Treatment.
Date & Time
- Saturday, March 1 | 1:00 PM – 2:15 PM
Location
- AGS Main Stage
Faculty Panel:
- Ike Ahmed, MD
- Reay Brown, MD
- Christine Funke, MD
- Zarmeena Vendal, MD
Gain insights into proactive glaucoma treatment strategies and the expanding role of interventional approaches in today’s evolving treatment landscape.
Meet the Experts: One-on-One Insights
Connect directly with renowned surgeons Nathan Radcliffe, MD, and Thomas W. Samuelson, MD, and gain firsthand insights into their experience with the OMNI® Surgical System, including the latest clinical data, and their approach to interventional glaucoma.
Location: Sight Sciences Booth 48
Meet-the-Expert Sessions:
- Thomas W. Samuelson, MD
- Thursday, February 27
- 11:15 – 11:45
- Nathan Radcliffe, MD
- Friday, February 28
- 11:15 – 11:45
Bring your questions, case discussions, and challenges—this is an excellent opportunity to learn from the best.
Exclusive Educational Dinners
Enhance your knowledge at our interactive dinner programs, featuring case discussions with leading experts.
Thursday, February 27, 2025
- Rising to the Challenge: Interventional Care for the Pseudophakic Glaucoma Patient
- Faculty: Noureen Khan, MD and Jason Bacharach, MD.
- Location: Fiola Mare Restaurant @ 8:00 PM
- RSVP at https://cvent.me/PBxOdm
Friday, February 28, 2025
- MIGS, proactive approaches to interventional glaucoma, and treating pseudophakic primary open-angle glaucoma patients
- For: Residents and fellows
- Faculty: Monisha Vora, MD
- Location: Founding Farmers Fishers & Bakers @ 7:00 pm
- RSVP with jxlayton@sightsciences.com
Friday, February 28, 2025
- Rising to the Challenge: Interventional Care for the Pseudophakic Glaucoma Patient
- Faculty: Usha Bulusu, MD and Matthew Brink, MD.
- Location: The Henri Restaurant @ 8:00 PM
- RSVP at https://cvent.me/drE8Wb
Posters and Presentations
We are pleased to have multiple presentations at AGS highlighting the robust clinical data supporting the use of OMNI in a variety of glaucoma patients. Don’t miss these opportunities to learn from the experts.
- Wednesday, February 26, 7:00 PM – 9:30 PM:
- Cocktails & Cases Super Bowl of Grand Rounds Cases (Presenting : Sandra Sieminski, MD, University at Buffalo)
- Thursday, February 27, 5:11 AM – 5:19 AM:
- “What’s your sign “GEMINI?”
(Presenting author: Mona Kaleem, MD, Johns Hopkins School of Medicine)
(Location: Regency Ballroom) – This presentation is part of the Surgery Day Section 5: AGS/ASCRS Symposium “From Sea to Shining Sea” – Landmark Trials in the MIGS Revolution.
- “What’s your sign “GEMINI?”
- Friday, February 28, 8:00 AM – 9:00 AM:
- Standalone Canaloplasty and Trabeculotomy Outcomes for Phakic and Pseudophakic Eyes: An American Academy of Ophthalmology IRIS® Registry (Intelligent Research in Sight) Analysis (Presenting author: Mark Pyfer, MD, Wills Eye Hospital) – This study demonstrated clinically and statistically significant IOP reductions in both phakic and pseudophakic eyes, with a significant increase in medication-free patients at 36 months.
- Ab Interno Minimally Invasive Glaucoma Surgery Effectiveness in Black Patients: IRIS® Registry Study (Presenting author: Leon Herndon, MD, Duke University) – This study showed that MIGS procedures, including OMNI, combined with cataract surgery in Black patients resulted in significant reductions in IOP and medication use.
- 36-Month Outcomes from the American Academy of Ophthalmology IRIS® Registry (Intelligent Research in Sight): Standalone Canaloplasty and Trabeculotomy in Eyes with Mild, Moderate, and Severe Primary Open-Angle Glaucoma (POAG) (Presenting author: Christine Funke, MD, Barnet Dulaney Perkin Eye Center) – This study demonstrated clinically and statistically significant IOP reductions across all glaucoma severity levels (mild, moderate, and severe) following standalone canaloplasty and trabeculotomy.
Note: All top poster presentations will be presented in the Ambassador Room
Have Questions?
For questions or additional information, email Rigo Magana at blog@sightsciences.com
Follow us on Social Media
Stay up to date with the latest events, news, expert tips, insights, and best practices!
Important Product Information
The OMNI® Surgical System is indicated for canaloplasty (microcatheterization and transluminal viscodilation of Schlemm’s canal) followed by trabeculotomy (cutting of trabecular meshwork) to reduce intraocular pressure in adult patients with primary open-angle glaucoma. Visit omnisurgical.com/ifu for the indications for use, contraindications, warnings, and potential adverse events. The SION® Surgical Instrument is a sterile, single use, manually operated device used in ophthalmic surgical procedures to excise trabecular meshwork. Visit sionsurgical.com/ifu for the indications for use, contraindications, warnings, and potential adverse events.
Ike Ahmed, MD; Jason Bacharach, MD; Matthew Brink, MD; Usha Bulusu, MD; Reay Brown, MD; Christine Funke, MD; Noureen Khan, MD; Nathan Radcliffe, MD; Thomas W. Samuelson, MD; Monisha Vora, MD; and Zarmeena Vendal, MD, are paid consultants of Sight Sciences.
© 2025 Sight Sciences. All rights reserved. Sight Sciences, the Sight Sciences logo, OMNI, and SION are registered trademarks of Sight Sciences. 02/2025 SS-3389-US.v1